Incidence of drug‐induced hepatic injuries: A French population‐based study

By C. Sgro, F. Clinard, Kader Ouazir, Henry Chanay, C. Allard, C. Guilleminet, C. Lenoir, A. Lemoine, P. Hillon. Hepatology, 2002

835 citations recorded by the source corpus.

Subfields: Emergency Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/ffcc4735be405f95c3c6bdbd177815a0a7807f67

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Heather J. Cordell
2. E. Bjornsson
3. T. Karlsen
4. G. Kullak-Ublick
5. Itsik Pe'er
6. D. Koch
7. W. Bernal
8. Matthew R. Nelson

Citations in the corpus

• Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study (2010, background): “9%) died.(10) In a 1990s United Kingdom-based survey,(11) DILI requiring specialist referral affected 2.”
• HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin (2009, background): “The standardized incidence rate of symptomatic hepatic adverse drug reaction (ADR) is 8 per 100,000 inhabitants, according to a French stud”
• EASL Clinical Practice Guidelines: Drug-induced liver injury. (2019, background): “9 cases per 100,000 inhabitants, which was at least 16 times more frequent than the reactions obtained through spontaneous reporting in France over the same time period.(43) A prospective study on DILI was also undertaken in Iceland over a 2-year study period.”